Cargando…
Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
Background: Immunotherapy has achieved remarkable success in treating advanced liver cancer. Current evidence shows that most of the available immune checkpoint inhibitor (ICB) treatments are suboptimal, and specific markers are needed for patients regarded as good candidates for immunotherapy. Necr...
Autores principales: | Peng, YunZhen, Wu, GuoJing, Qiu, Xin, Luo, Yue, Zou, YiShu, Wei, XueYan, Li, Aimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468751/ https://www.ncbi.nlm.nih.gov/pubmed/36110223 http://dx.doi.org/10.3389/fgene.2022.916024 |
Ejemplares similares
-
Construction of a Novel Prognostic Signature in Lung Adenocarcinoma Based on Necroptosis-Related lncRNAs
por: Diao, Xiayao, et al.
Publicado: (2022) -
Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs
por: Wang, Guowei, et al.
Publicado: (2022) -
Identification and validation of a prognostic model of necroptosis-related lncRNAs in hepatocellular carcinoma
por: Chen, Min, et al.
Publicado: (2022) -
Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma
por: Mo, Jiantao, et al.
Publicado: (2022) -
Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients
por: Wu, Jie, et al.
Publicado: (2022)